Decreased circulating branched-chain amino acids are associated with development of Alzheimer’s disease in elderly individuals with mild cognitive impairment
Authors:
Open Access
- 14 December 2022
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Nutrition
- Vol. 9, 1040476
Abstract
Background: Nutritional epidemiology has shown that inadequate dietary protein intake is associated with poor brain function in the elderly population. The plasma free amino acid (PFAA) profile reflects nutritional status and may have the potential to predict future changes in cognitive function. Here, we report the results of a 2-year interim analysis of a 3-year longitudinal study following mild cognitive impairment (MCI) participants.Method: In a multicenter prospective cohort design, MCI participants were recruited, and fasting plasma samples were collected. Based on clinical assessment of cognitive function up to 2 years after blood collection, MCI participants were divided into two groups: remained with MCI or reverted to cognitively normal (“MCI-stable,” N = 87) and converted to Alzheimer’s disease (AD) (“AD-convert,” N = 68). The baseline PFAA profile was compared between the two groups. Stratified analysis based on apolipoprotein E ε4 (APOE ε4) allele possession was also conducted.Results: Plasma concentrations of all nine essential amino acids (EAAs) were lower in the AD-convert group. Among EAAs, three branched-chain amino acids (BCAAs), valine, leucine and isoleucine, and histidine (His) exhibited significant differences even in the logistic regression model adjusted for potential confounding factors such as age, sex, body mass index (BMI), and APOE ε4 possession (p < 0.05). In the stratified analysis, differences in plasma concentrations of these four EAAs were more pronounced in the APOE ε4-negative group.Conclusion: The PFAA profile, especially decreases in BCAAs and His, is associated with development of AD in MCI participants, and the difference was larger in the APOE ε4-negative population, suggesting that the PFAA profile is an independent risk indicator for AD development. Measuring the PFAA profile may have importance in assessing the risk of AD conversion in the MCI population, possibly reflecting nutritional status.Clinical trial registration: [https://center6.umin.ac.jp/cgi-open-bin/ctr/ctr_view.cgi?recptno=R000025322], identifier [UMIN000021965].Keywords
This publication has 47 references indexed in Scilit:
- A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomised controlled trialThe Lancet, 2015
- Reference intervals for plasma-free amino acid in a Japanese populationAnnals of Clinical Biochemistry: International Journal of Laboratory Medicine, 2015
- Metabolite profiling for the identification of altered metabolic pathways in Alzheimer's diseaseJournal of Pharmaceutical and Biomedical Analysis, 2015
- Milk and Dairy Consumption and Risk of Dementia in an Elderly J apanese Population: The H isayama StudyJournal of the American Geriatrics Society, 2014
- Physical activity and risk of cognitive decline: a meta-analysis of prospective studiesJournal of Internal Medicine, 2010
- Risk Factors for Mild Cognitive Impairment in the Cardiovascular Health Study Cognition StudyArchives of Neurology, 2003
- Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer's diseaseProceedings of the National Academy of Sciences, 2000
- Amino acid concentrations in cerebrospinal fluid and plasma in Alzheimer's disease and healthy control subjectsJournal of Neural Transmission, 1990
- Tryptophan and nutritional status of patients with senile dementiaPsychological Medicine, 1986
- Association Between Nutritional Status and Cognitive Functioning in a Healthy Elderly PopulationJAMA, 1983